WMT

82.45

+0.4%↑

165.27

+0.17%↑

COST

885.66

+0.97%↑

+0.12%↑

PEP

166.25

+0.43%↑

WMT

82.45

+0.4%↑

165.27

+0.17%↑

COST

885.66

+0.97%↑

+0.12%↑

PEP

166.25

+0.43%↑

WMT

82.45

+0.4%↑

165.27

+0.17%↑

COST

885.66

+0.97%↑

+0.12%↑

PEP

166.25

+0.43%↑

WMT

82.45

+0.4%↑

165.27

+0.17%↑

COST

885.66

+0.97%↑

+0.12%↑

PEP

166.25

+0.43%↑

WMT

82.45

+0.4%↑

165.27

+0.17%↑

COST

885.66

+0.97%↑

+0.12%↑

PEP

166.25

+0.43%↑

Начало・Списък с акции・USANA Health Sciences Inc

USANA Health Sciences Inc

Отворен

37.71 1.32

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

37.12

Максимум

38.23

Ключови измерители
By Trading Economics
Продажби	221M
EPS	0.87
Служители	1,800

Препоръки
By TipRanks
Препоръки	Неутрален
12-месечна прогноза	-6.14 downside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	13M 911M
Предишно отваряне	36.39
Предишно затваряне	37.71

Техническа оценка

By Trading Central

Увереност

Very Strong Bullish Evidence

37.25 / 37.3 Подкрепа & съпротива

USANA Health Sciences Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.11.2024 г., 23:05 ч. UTC

Топ новини

Fitch Affirms Australia's Sovereign AAA Rating, But Warns Of Mounting Budget Risks

3.11.2024 г., 21:12 ч. UTC

Печалби

Westpac Says Annual Profit Falls 3%, Upbeat on Prospects -- Update

3.11.2024 г., 20:59 ч. UTC

Печалби

Westpac Says Annual Profit Falls 3%, Upbeat on Prospects

3.11.2024 г., 23:34 ч. UTC

Топ новини

Stocks Poised for Lower Open -- Barrons.com

3.11.2024 г., 23:16 ч. UTC

Топ новини

Печалби

Berkshire Hathway Earnings Weren't as Bad as They Looked -- Barrons.com

3.11.2024 г., 22:50 ч. UTC

Придобивния, сливания и поглъщания

Santos Says Working Interest in PNG LNG Now 39.9%

3.11.2024 г., 22:50 ч. UTC

Придобивния, сливания и поглъщания

Santos Says Kumul to Assume $90 Million of Project Finance Debt Associated With Stake

3.11.2024 г., 22:49 ч. UTC

Придобивния, сливания и поглъщания

Santos Says Final Payment Takes Total Cash Consideration to $602 Million

3.11.2024 г., 22:49 ч. UTC

Придобивния, сливания и поглъщания

Santos Receives Final $241 Million Payment From Kumul

3.11.2024 г., 22:48 ч. UTC

Придобивния, сливания и поглъщания

Santos Completes Sale of 2.6% Interest in PNG LNG to Kumul Petroleum

3.11.2024 г., 20:37 ч. UTC

Печалби

Westpac FY 2024 Deposits Increased 5% to A$674 Billion

3.11.2024 г., 20:37 ч. UTC

Печалби

Westpac FY 2024 Loans Increased 4% to A$807 Billion

3.11.2024 г., 20:37 ч. UTC

Печалби

Westpac FY 2024 Impairment Charges 7 Bps of Loans

3.11.2024 г., 20:37 ч. UTC

Печалби

Westpac FY 2024 Operating Expenses A$10.94 Billion, Up 7% Excluding Notable Items

3.11.2024 г., 20:36 ч. UTC

Печалби

Westpac FY 2024 Non-Interest Income A$2.84 Billion, Down 15%

3.11.2024 г., 20:35 ч. UTC

Печалби

Westpac FY 2024 CET1 Level 2 Capital Ratio 12.5%, Up 11 Bps

3.11.2024 г., 20:35 ч. UTC

Печалби

Westpac Raises Share Buyback Program by A$1 Billion

3.11.2024 г., 20:35 ч. UTC

Печалби

Westpac Final Dividend A$0.76/Share

3.11.2024 г., 20:33 ч. UTC

Печалби

Westpac FY 2024 Net Interest Margin Down 1 Bps at 1.95%

3.11.2024 г., 20:32 ч. UTC

Печалби

Westpac FY 2024 Revenue A$21.59 Billion, Flat on FY 2023

3.11.2024 г., 20:32 ч. UTC

Печалби

Westpac FY Net Profit A$6.99 Billion, Down 3%

3.11.2024 г., 18:09 ч. UTC

Топ новини

Boeing Had a Big Week. This One Is Even Bigger. -- Barrons.com

3.11.2024 г., 10:30 ч. UTC

Топ новини

Fed Prepares Rate Cut Amid Economic Contradictions -- WSJ

3.11.2024 г., 03:00 ч. UTC

Топ новини

Disgraced Lebanese Central Banker Who Was a Fugitive Now Awaits His Fate -- WSJ

2.11.2024 г., 13:53 ч. UTC

Топ новини

Печалби

Придобивния, сливания и поглъщания

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- Update

2.11.2024 г., 13:44 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2.11.2024 г., 13:00 ч. UTC

Топ новини

China's EV Makers Set Sights on Latin America in Global Expansion -- WSJ

2.11.2024 г., 12:58 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2.11.2024 г., 12:48 ч. UTC

Топ новини

Печалби

Придобивния, сливания и поглъщания

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- WSJ

2.11.2024 г., 12:32 ч. UTC

Печалби

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

USANA Health Sciences Inc Прогноза

Ценова цел

By TipRanks

-6.14% надолу

12-месечна прогноза

Среден 35 USD -6.14%

Висок 35 USD

Нисък 35 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за USANA Health Sciences Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на USANA Health Sciences Inc през последните 3 месеца.

Техническа оценка

By Trading Central

37.25 / 37.3Подкрепа & съпротива

Bullish events outweigh bearish events.

There is one bullish event.

There are no events.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно USANA Health Sciences Inc

USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal Care and Skincare and All Other. Its USANA Nutritionals Optimizers product line consists of supplements designed to meet individual health and nutritional needs. Its Essentials/CellSentials product line includes vitamin and mineral supplements that provides a total body nutrition for every age group beginning with children 13 months of age. Its Foods product line includes meal replacement shakes, snack bars, and other related products that provides macro-nutrition. Its Personal Care and Skincare product line includes its science-based personal care products and Celavive, its skincare system. Its All Other product line includes materials and online tools that are designed to assist its associates in building their businesses and in marketing its products.